{"id":339876,"date":"2025-08-19T19:18:19","date_gmt":"2025-08-19T19:18:19","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-transmedics\/"},"modified":"2025-08-19T19:18:19","modified_gmt":"2025-08-19T19:18:19","slug":"how-to-buy-transmedics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/","title":{"rendered":"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-339876","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"TransMedics Group (TMDX) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin, g\u00fcncel fiyat $124.14, riskler, b\u00fcy\u00fcme potansiyeli ve 2025-2030 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci hakk\u0131nda uzman analizi.","description_source":{"label":"Description","type":"textarea","formatted_value":"TransMedics Group (TMDX) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin, g\u00fcncel fiyat $124.14, riskler, b\u00fcy\u00fcme potansiyeli ve 2025-2030 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci hakk\u0131nda uzman analizi."},"intro":"Hayat kurtaran t\u0131bbi yeniliklere yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? TransMedics Group, organ naklini son teknoloji ile devrim niteli\u011finde de\u011fi\u015ftiriyor. Bu sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil - bu, insanlara kelimenin tam anlam\u0131yla ikinci bir ya\u015fam \u015fans\u0131 veren ve etkileyici finansal getiriler sunan bir \u015firket. TMDX'in neden dikkatinizi hak etti\u011fini ve bu hayat de\u011fi\u015ftiren yolculu\u011fun bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Hayat kurtaran t\u0131bbi yeniliklere yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? TransMedics Group, organ naklini son teknoloji ile devrim niteli\u011finde de\u011fi\u015ftiriyor. Bu sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil - bu, insanlara kelimenin tam anlam\u0131yla ikinci bir ya\u015fam \u015fans\u0131 veren ve etkileyici finansal getiriler sunan bir \u015firket. TMDX'in neden dikkatinizi hak etti\u011fini ve bu hayat de\u011fi\u015ftiren yolculu\u011fun bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 TransMedics Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>19 A\u011fustos 2025 itibar\u0131yla TransMedics Group (TMDX) hissesi <strong>124,14 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Ancak takviminize i\u015faretleyin - <strong>27 Ekim 2025<\/strong> hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilecek bir sonraki b\u00fcy\u00fck kataliz\u00f6r.<\/p> <p><strong>27 Ekim Neden \u00d6nemli:<\/strong><br> Bu tarihte TransMedics, 2025 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayacak. Tarihsel olarak, kazan\u00e7 a\u00e7\u0131klamalar\u0131 \u00f6nemli fiyat hareketlerine yol a\u00e7m\u0131\u015ft\u0131r. Son d\u00f6neme bakarsak:<\/p> <ul> <li><strong>30 Temmuz 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri a\u015ft\u0131, 0,92 $ EPS vs 0,48 $ tahmini - hisse hemen ard\u0131ndan <strong>%10,5<\/strong> y\u00fckseldi<\/li> <li><strong>29 Nisan 2025<\/strong>: 1. \u00e7eyrek sonu\u00e7lar\u0131 b\u00fcy\u00fcme ivmesini s\u00fcrd\u00fcrd\u00fc - hisseler sonraki hafta <strong>%8,2<\/strong> kazand\u0131<\/li> <li><strong>28 Ocak 2025<\/strong>: G\u00fc\u00e7l\u00fc 4. \u00e7eyrek 2024 sonu\u00e7lar\u0131 - hisse iki hafta i\u00e7inde <strong>%12,1<\/strong> y\u00fckseldi<\/li> <\/ul> <p>Desen a\u00e7\u0131k: TransMedics s\u00fcrekli olarak tahminleri a\u015fmakta ve piyasa bu performans\u0131 c\u00f6mert\u00e7e \u00f6d\u00fcllendirmektedir. Her kazan\u00e7 raporu \u00e7ift haneli y\u00fczdelik hareketler tetikleyerek bu tarihleri giri\u015f ve \u00e7\u0131k\u0131\u015f zamanlamas\u0131 i\u00e7in kritik k\u0131lmaktad\u0131r.<\/p>  [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u00d6d\u00fcllerle Dolu Bir Rollercoaster<\/h2> <p>TransMedics, son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a hareketli bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr> <th>Ay<\/th> <th>Fiyat Aral\u0131\u011f\u0131<\/th> <th>\u00d6nemli Olaylar<\/th> <\/tr> <\/thead> <tbody> <tr> <td>\u015eubat 2025<\/td> <td>85-95 $<\/td> <td>Tatil sonras\u0131 konsolidasyon<\/td> <\/tr> <tr> <td>Mart 2025<\/td> <td>98-112 $<\/td> <td>FDA onay s\u00f6ylentileri art\u0131yor<\/td> <\/tr> <tr> <td>Nisan 2025<\/td> <td>115-130 $<\/td> <td>1. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri a\u015ft\u0131<\/td> <\/tr> <tr> <td>May\u0131s 2025<\/td> <td>125-140 $<\/td> <td>Kurumsal al\u0131mlar devam etti<\/td> <\/tr> <tr> <td>Haziran 2025<\/td> <td>135-150 $<\/td> <td>Piyasa genelinde teknoloji rallisi<\/td> <\/tr> <tr> <td>Temmuz 2025<\/td> <td>145-160 $<\/td> <td>2. \u00e7eyrek m\u00fcthi\u015f kazan\u00e7lar + FDA onay\u0131<\/td> <\/tr> <tr> <td>A\u011fustos 2025<\/td> <td>120-130 $<\/td> <td>K\u00e2r realizasyonu ve konsolidasyon<\/td> <\/tr> <\/tbody> <\/table> <p>Hisse bu alt\u0131 ayl\u0131k d\u00f6nemde yakla\u015f\u0131k <strong>%46<\/strong> de\u011fer kazand\u0131 ve sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn genel performans\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde geride b\u0131rakt\u0131. Bu volatilite cesaret isteyen bir durumdur - TMDX'in beta de\u011feri 2,08 olup, piyasa genelinden iki kat daha oynakt\u0131r.<\/p>  <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket rehberli\u011fine dayanarak, gelecekte \u015funlar olabilir:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 160-175 $ (mevcut seviyelerden %29-41 art\u0131\u015f)<br> <em>Neden: G\u00fc\u00e7l\u00fc 2. yar\u0131 performans\u0131, NOP program\u0131n\u0131n geni\u015flemesi<\/em><\/p> <p><strong>2026 Hedefi<\/strong>: 190-210 $ (%53-69 b\u00fcy\u00fcme potansiyeli)<br> <em>Neden: FDA onaylar\u0131n\u0131n tam y\u0131l etkisi, uluslararas\u0131 geni\u015fleme<\/em><\/p> <p><strong>2028 Projeksiyonu<\/strong>: 250-280 $ (%101-126 toplam getiri)<br> <em>Neden: 1 milyar $ gelir hedefi, pazar hakimiyeti<\/em><\/p> <p><strong>2030 Vizyonu<\/strong>: 300-350 $ (%142-182 uzun vadeli de\u011fer art\u0131\u015f\u0131)<br> <em>Neden: K\u00fcresel benimseme, yeni organ sistemleri geli\u015ftirmeleri<\/em><\/p> <p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Teknolojik liderlik, geni\u015fleyen adreslenebilir pazar ve tutarl\u0131 uygulama birle\u015fimi TMDX'i cazip bir b\u00fcy\u00fcme hikayesi yap\u0131yor.<\/p>  <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/h3> <ul> <li><strong>Y\u00fcksek De\u011ferleme<\/strong>: 47,24 ileriye d\u00f6n\u00fck F\/K oran\u0131 primli fiyatlamay\u0131 g\u00f6steriyor<\/li> <li><strong>Reg\u00fclasyon Ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: FDA onaylar\u0131 b\u00fcy\u00fcme i\u00e7in kritik<\/li> <li><strong>Pazar Konsantrasyonu<\/strong>: Gelirin %76's\u0131 karaci\u011fer naklinden geliyor<\/li> <li><strong>Volatilite<\/strong>: 2,08 beta de\u011feri vah\u015fi fiyat dalgalanmalar\u0131 anlam\u0131na geliyor<\/li> <li><strong>K\u00e2rl\u0131l\u0131k Zamanlamas\u0131<\/strong>: B\u00fcy\u00fcme i\u00e7in hala nakit yak\u0131yor<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/h3> <ul> <li><strong>FDA Onay\u0131<\/strong>: Next-Gen OCS Akci\u011fer denemesi i\u00e7in ko\u015fullu IDE verildi<\/li> <li><strong>Gelir Rehberli\u011fi Y\u00fckseltildi<\/strong>: 2025 i\u00e7in \u015fimdi 585-605 milyon $ hedefleniyor<\/li> <li><strong>Pazar Geni\u015flemesi<\/strong>: Hava ta\u015f\u0131mac\u0131l\u0131\u011f\u0131 gerektiren NOP g\u00f6revlerinin %79'unu kaps\u0131yor<\/li> <li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Organ nakli hacmi %12 b\u00fcy\u00fcyor, tarihsel %3-4'e kar\u015f\u0131<\/li> <li><strong>Teknolojik \u00dcst\u00fcnl\u00fck<\/strong>: D\u00fc\u015f\u00fck penetrasyon oranlar\u0131na sahip \u00fc\u00e7 FDA onayl\u0131 sistem (4-18%)<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2'si ile ba\u015flay\u0131n - bu hisse h\u0131zl\u0131 hareket ediyor<\/li> <li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Kazan\u00e7 tarihleri civar\u0131nda par\u00e7a par\u00e7a al\u0131m yap\u0131n<\/li> <li><strong>Stop-Loss Belirleyin<\/strong>: Giri\u015f fiyat\u0131n\u0131n %15-20 alt\u0131nda volatilite riskini y\u00f6netin<\/li> <li><strong>FDA Haberlerini Takip Edin<\/strong>: Reg\u00fclasyon onaylar\u0131 b\u00fcy\u00fck kataliz\u00f6rlerdir<\/li> <\/ol> <p>Esprili bir not: \"TMDX ticareti yapmak, bir organ nakli cerrah\u0131 gibi olmak gibidir - volatilite s\u0131ras\u0131nda sabit eller hastay\u0131 (ve portf\u00f6y\u00fcn\u00fcz\u00fc) kurtar\u0131r!\"<\/p>  <h2>\u2705 TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir Ticaret Platformu Se\u00e7in<\/td> <td>NASDAQ eri\u015fimi ve par\u00e7al\u0131 hisse sunan bir platform se\u00e7in<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td> <td>Y\u00f6netilebilir bir miktarla ba\u015flay\u0131n - 100 $ bile yeterli<\/td> <\/tr> <tr> <td>3<\/td> <td>\"TMDX\" Aray\u0131n<\/td> <td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td> <td>Daha iyi giri\u015f i\u00e7in 120-125 $ civar\u0131nda limit emirleri kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>\u0130nceleyin ve Ger\u00e7ekle\u015ftirin<\/td> <td>Komisyon oranlar\u0131n\u0131 kontrol edin - %0,5'in alt\u0131nda hedefleyin<\/td> <\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Neden Pocket Option Yeni T\u0131bbi Hisse Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>TransMedics gibi yenilik\u00e7i \u015firketlere yat\u0131r\u0131m yapmak isteyenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Sadece 5 $ minimum depozito<\/strong> - T\u0131bbi hisselerde volatiliteye kar\u015f\u0131 strateji test etmek i\u00e7in m\u00fckemmel<\/li> <li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> - Herhangi bir kimlik belgesini y\u00fckleyin ve hemen ticarete ba\u015flay\u0131n<\/li> <li><strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> - Kripto, e-c\u00fczdanlar ve geleneksel banka transferleri dahil<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc olmadan ileri teknoloji t\u0131bbi teknolojiye maruz kalmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>  <h2>\ud83c\udf0d 2025'te TransMedics: Organ Naklinde Devrim<\/h2> <p>TransMedics sadece ba\u015fka bir t\u0131bbi cihaz \u015firketi de\u011fil - organ nakillerinin \u00e7al\u0131\u015fma \u015feklini k\u00f6kten de\u011fi\u015ftiriyor. Organ Bak\u0131m Sistemi (OCS) teknolojileri, organlar\u0131 v\u00fccut d\u0131\u015f\u0131nda canl\u0131 tutarak nakil ba\u015far\u0131 oranlar\u0131n\u0131 dramatik \u015fekilde art\u0131r\u0131yor ve don\u00f6r havuzunu geni\u015fletiyor.<\/p> <p>\u015eirket \u015fu anda <strong>\u00fc\u00e7 organ kategorisinde pazar liderli\u011fine<\/strong> (kalp, karaci\u011fer, akci\u011fer) sahip ve son iki y\u0131lda ABD nakillerindeki %20 b\u00fcy\u00fcmenin neredeyse tamam\u0131ndan sorumlu. 103.000'den fazla Amerikal\u0131 nakil bekleme listesinde oldu\u011fundan, adreslenebilir pazar \u00e7ok b\u00fcy\u00fck ve b\u00fcy\u00fcyor.<\/p> <p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: TransMedics'in yeni dijital ekosistemi OCS NOP ACCESS, ABD genelindeki b\u00fcy\u00fck nakil programlar\u0131n\u0131 birbirine ba\u011fl\u0131yor ve asl\u0131nda \"organ ta\u015f\u0131mac\u0131l\u0131\u011f\u0131 i\u00e7in Uber\" gibi \u00e7al\u0131\u015f\u0131yor - mevcut organlar\u0131 al\u0131c\u0131larla ger\u00e7ek zamanl\u0131 e\u015fle\u015ftirirken yol boyunca m\u00fckemmel koruma ko\u015fullar\u0131n\u0131 sa\u011fl\u0131yor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 TransMedics Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>19 A\u011fustos 2025 itibar\u0131yla TransMedics Group (TMDX) hissesi <strong>124,14 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Ancak takviminize i\u015faretleyin &#8211; <strong>27 Ekim 2025<\/strong> hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilecek bir sonraki b\u00fcy\u00fck kataliz\u00f6r.<\/p>\n<p><strong>27 Ekim Neden \u00d6nemli:<\/strong><br \/> Bu tarihte TransMedics, 2025 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayacak. Tarihsel olarak, kazan\u00e7 a\u00e7\u0131klamalar\u0131 \u00f6nemli fiyat hareketlerine yol a\u00e7m\u0131\u015ft\u0131r. Son d\u00f6neme bakarsak:<\/p>\n<ul>\n<li><strong>30 Temmuz 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri a\u015ft\u0131, 0,92 $ EPS vs 0,48 $ tahmini &#8211; hisse hemen ard\u0131ndan <strong>%10,5<\/strong> y\u00fckseldi<\/li>\n<li><strong>29 Nisan 2025<\/strong>: 1. \u00e7eyrek sonu\u00e7lar\u0131 b\u00fcy\u00fcme ivmesini s\u00fcrd\u00fcrd\u00fc &#8211; hisseler sonraki hafta <strong>%8,2<\/strong> kazand\u0131<\/li>\n<li><strong>28 Ocak 2025<\/strong>: G\u00fc\u00e7l\u00fc 4. \u00e7eyrek 2024 sonu\u00e7lar\u0131 &#8211; hisse iki hafta i\u00e7inde <strong>%12,1<\/strong> y\u00fckseldi<\/li>\n<\/ul>\n<p>Desen a\u00e7\u0131k: TransMedics s\u00fcrekli olarak tahminleri a\u015fmakta ve piyasa bu performans\u0131 c\u00f6mert\u00e7e \u00f6d\u00fcllendirmektedir. Her kazan\u00e7 raporu \u00e7ift haneli y\u00fczdelik hareketler tetikleyerek bu tarihleri giri\u015f ve \u00e7\u0131k\u0131\u015f zamanlamas\u0131 i\u00e7in kritik k\u0131lmaktad\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u00d6d\u00fcllerle Dolu Bir Rollercoaster<\/h2>\n<p>TransMedics, son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a hareketli bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Ay<\/th>\n<th>Fiyat Aral\u0131\u011f\u0131<\/th>\n<th>\u00d6nemli Olaylar<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>\u015eubat 2025<\/td>\n<td>85-95 $<\/td>\n<td>Tatil sonras\u0131 konsolidasyon<\/td>\n<\/tr>\n<tr>\n<td>Mart 2025<\/td>\n<td>98-112 $<\/td>\n<td>FDA onay s\u00f6ylentileri art\u0131yor<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>115-130 $<\/td>\n<td>1. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri a\u015ft\u0131<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2025<\/td>\n<td>125-140 $<\/td>\n<td>Kurumsal al\u0131mlar devam etti<\/td>\n<\/tr>\n<tr>\n<td>Haziran 2025<\/td>\n<td>135-150 $<\/td>\n<td>Piyasa genelinde teknoloji rallisi<\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2025<\/td>\n<td>145-160 $<\/td>\n<td>2. \u00e7eyrek m\u00fcthi\u015f kazan\u00e7lar + FDA onay\u0131<\/td>\n<\/tr>\n<tr>\n<td>A\u011fustos 2025<\/td>\n<td>120-130 $<\/td>\n<td>K\u00e2r realizasyonu ve konsolidasyon<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Hisse bu alt\u0131 ayl\u0131k d\u00f6nemde yakla\u015f\u0131k <strong>%46<\/strong> de\u011fer kazand\u0131 ve sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn genel performans\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde geride b\u0131rakt\u0131. Bu volatilite cesaret isteyen bir durumdur &#8211; TMDX&#8217;in beta de\u011feri 2,08 olup, piyasa genelinden iki kat daha oynakt\u0131r.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket rehberli\u011fine dayanarak, gelecekte \u015funlar olabilir:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 160-175 $ (mevcut seviyelerden %29-41 art\u0131\u015f)<br \/> <em>Neden: G\u00fc\u00e7l\u00fc 2. yar\u0131 performans\u0131, NOP program\u0131n\u0131n geni\u015flemesi<\/em><\/p>\n<p><strong>2026 Hedefi<\/strong>: 190-210 $ (%53-69 b\u00fcy\u00fcme potansiyeli)<br \/> <em>Neden: FDA onaylar\u0131n\u0131n tam y\u0131l etkisi, uluslararas\u0131 geni\u015fleme<\/em><\/p>\n<p><strong>2028 Projeksiyonu<\/strong>: 250-280 $ (%101-126 toplam getiri)<br \/> <em>Neden: 1 milyar $ gelir hedefi, pazar hakimiyeti<\/em><\/p>\n<p><strong>2030 Vizyonu<\/strong>: 300-350 $ (%142-182 uzun vadeli de\u011fer art\u0131\u015f\u0131)<br \/> <em>Neden: K\u00fcresel benimseme, yeni organ sistemleri geli\u015ftirmeleri<\/em><\/p>\n<p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Teknolojik liderlik, geni\u015fleyen adreslenebilir pazar ve tutarl\u0131 uygulama birle\u015fimi TMDX&#8217;i cazip bir b\u00fcy\u00fcme hikayesi yap\u0131yor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/h3>\n<ul>\n<li><strong>Y\u00fcksek De\u011ferleme<\/strong>: 47,24 ileriye d\u00f6n\u00fck F\/K oran\u0131 primli fiyatlamay\u0131 g\u00f6steriyor<\/li>\n<li><strong>Reg\u00fclasyon Ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: FDA onaylar\u0131 b\u00fcy\u00fcme i\u00e7in kritik<\/li>\n<li><strong>Pazar Konsantrasyonu<\/strong>: Gelirin %76&#8217;s\u0131 karaci\u011fer naklinden geliyor<\/li>\n<li><strong>Volatilite<\/strong>: 2,08 beta de\u011feri vah\u015fi fiyat dalgalanmalar\u0131 anlam\u0131na geliyor<\/li>\n<li><strong>K\u00e2rl\u0131l\u0131k Zamanlamas\u0131<\/strong>: B\u00fcy\u00fcme i\u00e7in hala nakit yak\u0131yor<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/h3>\n<ul>\n<li><strong>FDA Onay\u0131<\/strong>: Next-Gen OCS Akci\u011fer denemesi i\u00e7in ko\u015fullu IDE verildi<\/li>\n<li><strong>Gelir Rehberli\u011fi Y\u00fckseltildi<\/strong>: 2025 i\u00e7in \u015fimdi 585-605 milyon $ hedefleniyor<\/li>\n<li><strong>Pazar Geni\u015flemesi<\/strong>: Hava ta\u015f\u0131mac\u0131l\u0131\u011f\u0131 gerektiren NOP g\u00f6revlerinin %79&#8217;unu kaps\u0131yor<\/li>\n<li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Organ nakli hacmi %12 b\u00fcy\u00fcyor, tarihsel %3-4&#8217;e kar\u015f\u0131<\/li>\n<li><strong>Teknolojik \u00dcst\u00fcnl\u00fck<\/strong>: D\u00fc\u015f\u00fck penetrasyon oranlar\u0131na sahip \u00fc\u00e7 FDA onayl\u0131 sistem (4-18%)<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %1-2&#8217;si ile ba\u015flay\u0131n &#8211; bu hisse h\u0131zl\u0131 hareket ediyor<\/li>\n<li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Kazan\u00e7 tarihleri civar\u0131nda par\u00e7a par\u00e7a al\u0131m yap\u0131n<\/li>\n<li><strong>Stop-Loss Belirleyin<\/strong>: Giri\u015f fiyat\u0131n\u0131n %15-20 alt\u0131nda volatilite riskini y\u00f6netin<\/li>\n<li><strong>FDA Haberlerini Takip Edin<\/strong>: Reg\u00fclasyon onaylar\u0131 b\u00fcy\u00fck kataliz\u00f6rlerdir<\/li>\n<\/ol>\n<p>Esprili bir not: &#8220;TMDX ticareti yapmak, bir organ nakli cerrah\u0131 gibi olmak gibidir &#8211; volatilite s\u0131ras\u0131nda sabit eller hastay\u0131 (ve portf\u00f6y\u00fcn\u00fcz\u00fc) kurtar\u0131r!&#8221;<\/p>\n<h2>\u2705 TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve par\u00e7al\u0131 hisse sunan bir platform se\u00e7in<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Y\u00f6netilebilir bir miktarla ba\u015flay\u0131n &#8211; 100 $ bile yeterli<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;TMDX&#8221; Aray\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Daha iyi giri\u015f i\u00e7in 120-125 $ civar\u0131nda limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Ger\u00e7ekle\u015ftirin<\/td>\n<td>Komisyon oranlar\u0131n\u0131 kontrol edin &#8211; %0,5&#8217;in alt\u0131nda hedefleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni T\u0131bbi Hisse Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>TransMedics gibi yenilik\u00e7i \u015firketlere yat\u0131r\u0131m yapmak isteyenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Sadece 5 $ minimum depozito<\/strong> &#8211; T\u0131bbi hisselerde volatiliteye kar\u015f\u0131 strateji test etmek i\u00e7in m\u00fckemmel<\/li>\n<li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> &#8211; Herhangi bir kimlik belgesini y\u00fckleyin ve hemen ticarete ba\u015flay\u0131n<\/li>\n<li><strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> &#8211; Kripto, e-c\u00fczdanlar ve geleneksel banka transferleri dahil<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc olmadan ileri teknoloji t\u0131bbi teknolojiye maruz kalmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te TransMedics: Organ Naklinde Devrim<\/h2>\n<p>TransMedics sadece ba\u015fka bir t\u0131bbi cihaz \u015firketi de\u011fil &#8211; organ nakillerinin \u00e7al\u0131\u015fma \u015feklini k\u00f6kten de\u011fi\u015ftiriyor. Organ Bak\u0131m Sistemi (OCS) teknolojileri, organlar\u0131 v\u00fccut d\u0131\u015f\u0131nda canl\u0131 tutarak nakil ba\u015far\u0131 oranlar\u0131n\u0131 dramatik \u015fekilde art\u0131r\u0131yor ve don\u00f6r havuzunu geni\u015fletiyor.<\/p>\n<p>\u015eirket \u015fu anda <strong>\u00fc\u00e7 organ kategorisinde pazar liderli\u011fine<\/strong> (kalp, karaci\u011fer, akci\u011fer) sahip ve son iki y\u0131lda ABD nakillerindeki %20 b\u00fcy\u00fcmenin neredeyse tamam\u0131ndan sorumlu. 103.000&#8217;den fazla Amerikal\u0131 nakil bekleme listesinde oldu\u011fundan, adreslenebilir pazar \u00e7ok b\u00fcy\u00fck ve b\u00fcy\u00fcyor.<\/p>\n<p><strong>2025 i\u00e7in \u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: TransMedics&#8217;in yeni dijital ekosistemi OCS NOP ACCESS, ABD genelindeki b\u00fcy\u00fck nakil programlar\u0131n\u0131 birbirine ba\u011fl\u0131yor ve asl\u0131nda &#8220;organ ta\u015f\u0131mac\u0131l\u0131\u011f\u0131 i\u00e7in Uber&#8221; gibi \u00e7al\u0131\u015f\u0131yor &#8211; mevcut organlar\u0131 al\u0131c\u0131larla ger\u00e7ek zamanl\u0131 e\u015fle\u015ftirirken yol boyunca m\u00fckemmel koruma ko\u015fullar\u0131n\u0131 sa\u011fl\u0131yor.<\/p>\n"},"faq":[{"question":"TransMedics hisseleri nereden al\u0131nabilir?","answer":"TransMedics hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"TMDX hissesi i\u00e7in riskler nelerdir?","answer":"Y\u00fcksek de\u011ferleme, FDA onaylar\u0131na ba\u011f\u0131ml\u0131l\u0131k, pazar konsantrasyonu ve y\u00fcksek volatilite TMDX hissesi i\u00e7in ba\u015fl\u0131ca risklerdir."},{"question":"TransMedics'in b\u00fcy\u00fcme potansiyeli nedir?","answer":"Analist projeksiyonlar\u0131na g\u00f6re 2025-2030 aras\u0131nda %29'dan %182'ye kadar de\u011fer art\u0131\u015f\u0131 beklenmektedir, g\u00fc\u00e7l\u00fc teknolojik liderlik ve pazar geni\u015flemesi ile desteklenmektedir."},{"question":"Yeni ba\u015flayanlar TMDX hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, stop-loss kullan\u0131n ve FDA haberlerini yak\u0131ndan takip edin."},{"question":"Pocket Option neden t\u0131bbi hisse yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile Pocket Option, t\u0131bbi teknoloji hisselerine yat\u0131r\u0131m yapmak isteyenler i\u00e7in ideal bir platformdur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"TransMedics hisseleri nereden al\u0131nabilir?","answer":"TransMedics hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"TMDX hissesi i\u00e7in riskler nelerdir?","answer":"Y\u00fcksek de\u011ferleme, FDA onaylar\u0131na ba\u011f\u0131ml\u0131l\u0131k, pazar konsantrasyonu ve y\u00fcksek volatilite TMDX hissesi i\u00e7in ba\u015fl\u0131ca risklerdir."},{"question":"TransMedics'in b\u00fcy\u00fcme potansiyeli nedir?","answer":"Analist projeksiyonlar\u0131na g\u00f6re 2025-2030 aras\u0131nda %29'dan %182'ye kadar de\u011fer art\u0131\u015f\u0131 beklenmektedir, g\u00fc\u00e7l\u00fc teknolojik liderlik ve pazar geni\u015flemesi ile desteklenmektedir."},{"question":"Yeni ba\u015flayanlar TMDX hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yap\u0131n, stop-loss kullan\u0131n ve FDA haberlerini yak\u0131ndan takip edin."},{"question":"Pocket Option neden t\u0131bbi hisse yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile Pocket Option, t\u0131bbi teknoloji hisselerine yat\u0131r\u0131m yapmak isteyenler i\u00e7in ideal bir platformdur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-19T19:18:19+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-19T19:18:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/\",\"name\":\"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-19T19:18:19+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/","og_locale":"tr_TR","og_type":"article","og_title":"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-19T19:18:19+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-19T19:18:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/","name":"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-19T19:18:19+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-transmedics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"TransMedics Group, Inc. (TMDX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; TransMedics Group, Inc. (TMDX) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":339881,"slug":"how-to-buy-transmedics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu TransMedics Group, Inc. (TMDX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu TransMedics Group, Inc. (TMDX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-transmedics\/"},"pt_AA":{"locale":"pt_AA","id":339880,"slug":"how-to-buy-transmedics","post_title":"Como comprar a\u00e7\u00f5es da TransMedics Group, Inc. (TMDX) - Investimento em a\u00e7\u00f5es da TransMedics Group, Inc. (TMDX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-transmedics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/339876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=339876"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/339876\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=339876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=339876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=339876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}